Pharmarise Holdings Corp.

51
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
  • TKS: 2796
JPY
504.00
-3 (-0.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
May'26
May'25
May'24
May'23
May'22
May'21
No of Months
12
12
12
12
12
12
Operating Income
69,512.00
63,508.00
54,466.00
52,030.00
51,608.00
52,324.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
69,512.00
63,508.00
54,466.00
52,030.00
51,608.00
52,324.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
285.00
178.00
66.00
55.00
65.00
75.00
General and Administration Expenses
4,440.00
4,851.00
4,359.00
3,715.00
3,514.00
3,644.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
65,326.00
60,165.00
50,945.00
48,259.00
47,716.00
48,660.00
Operating Profit (PBDIT) excl Other Income
4,186.00
3,343.00
3,521.00
3,771.00
3,892.00
3,664.00
Other Income
11.00
21.00
-4.00
1.00
-21.00
85.00
Operating Profit (PBDIT)
2,596.00
1,809.00
2,082.00
2,664.00
2,808.00
2,676.00
Interest
285.00
178.00
66.00
55.00
65.00
75.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
1,605.00
1,493.00
1,170.00
1,224.00
1,308.00
1,344.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
698.00
8.00
143.00
1,049.00
1,322.00
1,202.00
Provision for Tax
591.00
390.00
485.00
702.00
864.00
782.00
Profit After Tax
113.00
-368.00
-351.00
333.00
448.00
425.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
9.56
-32.42
-33.35
26.86
36.22
34.59
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2026 is 9.45% vs 16.60% in May 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2026 is 25.22% vs -5.06% in May 2025

stock-summary

Interest

YoY Growth in year ended May 2026 is 60.11% vs 169.70% in May 2025

stock-summary

Profit After Tax

YoY Growth in year ended May 2026 is 130.71% vs -4.84% in May 2025

Compare Profit and Loss Results of Pharmarise Holdings Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
69,512.00
68.00
69,444.00
102,123.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
69,512.00
68.00
69,444.00
102,123.53%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
33.00
-33.00
-100.00%
Operating Expenses
285.00
0.00
285.00
0%
General and Administration Expenses
4,440.00
195.00
4,245.00
2,176.92%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
65,326.00
401.00
64,925.00
16,190.77%
Operating Profit (PBDIT) excl Other Income
4,186.00
-333.00
4,519.00
1,357.06%
Other Income
11.00
56.00
-45.00
-80.36%
Operating Profit (PBDIT)
2,596.00
-300.00
2,896.00
965.33%
Interest
285.00
0.00
285.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
1,605.00
0.00
1,605.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
698.00
-300.00
998.00
332.67%
Provision for Tax
591.00
1.00
590.00
59,000.00%
Profit After Tax
113.00
-301.00
414.00
137.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.5638
-23.3943
32.96
140.88%
Profit And Loss - Net Sales
Net Sales 69,512.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 9.45% vs 16.60% in May 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,186.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 25.22% vs -5.06% in May 2025

Profit And Loss - Interest
Interest 285.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 60.11% vs 169.70% in May 2025

Profit And Loss - Profit After Tax
Profit After Tax 113.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 130.71% vs -4.84% in May 2025

Footer loading